Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?

Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.

A meta-analysis was conducted to determine the impact of physical activity on cognition improvement in patients with diabetes.

Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin. 

The prevalence of gestational diabetes may be related to the duration of sleep among pregnant women. 

Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?

With the introduction of this new biosimilar insulin, patients with diabetes will have the opportunity to have easier and broader access to insulin therapy, and a more affordable option than those already on the market. 

Pediatric patients with T2D have accelerated onset of hypertension, dyslipidemia, kidney disease, nerve disease, and diabetic retinopathy.

Recently completed research examines the effect of consistent cycling on all-cause and cardiovascular mortality.

Investigating whether a low-carb diet can lead to diabetes remission.